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Objectives This study sought to elucidate the mechanisms responsible for the benefits of small muscle mass exercise train-
ing in patients with chronic heart failure (CHF).
Background How central cardiorespiratory and/or peripheral skeletal muscle factors are altered with small muscle mass
training in CHF is unknown.
Methods We studied muscle structure, and oxygen (O2) transport and metabolism at maximal cycle (whole-body) and
knee-extensor exercise (KE) (small muscle mass) in 6 healthy controls and 6 patients with CHF who then per-
formed 8 weeks of KE training (both legs, separately) and repeated these assessments.
Results Pre-training cycling and KE peak leg O2 uptake (VO2peak) were 17% and 15% lower, respectively, in the pa-
tients compared with controls. Structurally, KE training increased quadriceps muscle capillarity and mitochon-
drial density by 21% and 25%, respectively. Functionally, despite not altering maximal cardiac output, KE
training increased maximal O2 delivery (54%), arterial-venous O2 difference (10%), and muscle O2 diffusive
conductance (DMO2) (39%) (assessed during KE), thereby increasing single-leg VO2peak by 53%, to a level ex-
ceeding that of the untrained controls. Post-training, during maximal cycling, O2 delivery (40%), arterial-venous
O2 difference (15%), and DMO2 (52%) all increased, yielding an increase in VO2peak of 40%, matching the
controls.
Conclusions In the face of continued central limitations, clear improvements in muscle structure, peripheral convective and
diffusive O2 transport, and subsequently, O2 utilization support the efficacy of local skeletal muscle training as a
powerful approach to combat exercise intolerance in CHF. (J Am Coll Cardiol 2011;58:1353–62) © 2011 by
the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.06.025s
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cDiminished maximal exercise capacity is a defining symp-
tom of chronic heart failure (CHF), limiting physical
activity and impairing quality of life (1). Regular exercise in
patients with CHF improves quality of life and reduces
symptoms, hospitalization, disability, and even, perhaps,
mortality (2–4). Traditionally, this attenuated exercise ca-
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accepted June 27, 2011.pacity has been attributed predominantly to the “central”
hemodynamic limitations associated with the failing cardiac
pump, but it is now evident that “peripheral” factors also
contribute to this exercise limitation, as first highlighted by
the work of Poole and Musch in a rat model of CHF (5,6)
and later confirmed in humans (7). However, due to the
multifactorial determinants of maximal exercise and its
associated O2 consumption, Vo2peak, the mechanisms re-
ponsible for the beneficial effects of exercise training, and
herefore exercise prescription, in patients with CHF are
ot yet completely understood.
Traditional cardiac rehabilitation has employed whole-
ody exercise, which challenges a large muscle mass and
herefore taxes the central circulation. This approach has
onsistently yielded significant improvements in exercise
apacity in patients with CHF (3,8). However, because
hole-body exercise induces a complex interaction between
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Peripheral Adaptation in Heart Failure September 20, 2011:1353–62central hemodynamic and pe-
ripheral responses, such an ob-
servation leaves doubt as to the
role of central and peripheral ad-
aptations in response to exercise
training. In an attempt to address
this uncertainty, several studies
have employed small muscle
mass training, unlikely to stimu-
late central hemodynamic adap-
tations, and then challenged the
patients with whole-body exer-
cise (9–11). Although this inno-
vative approach has revealed that
muscle-specific training can in-
deed improve whole-body exer-
cise capacity in patients with
CHF (9–11), the indirect phys-
iological assessments used in these studies mean that the
mechanisms responsible for this positive outcome have yet
to be determined.
Consequently, utilizing direct intramuscular and intravas-
cular measurements, this study sought to determine the
physiological mechanisms responsible for the anticipated
improvement in whole-body exercise capacity following 8
weeks of isolated knee-extensor exercise (KE) training in
patients with CHF. Specifically, it was hypothesized that
small muscle mass training will: 1) stimulate intramuscular
structural changes that are conducive to O2 transport and
xidative metabolism (e.g., increased capillarity and mito-
hondrial density); 2) significantly improve muscle O2
diffusional conductance; 3) significantly enhance skeletal
muscle O2 delivery; and subsequently, 4) improve VO2peak,
ssessed both locally (across the muscle) and centrally
across the lungs), despite only a minimal central hemody-
amic challenge and therefore nominal central adaptation.
e further hypothesized that improvement in exercise
apacity would be evident, not only during KE, but also in
hole-body (cycling) exercise. If these hypotheses are sup-
orted by experimental data, they will provide direct evi-
ence of the important role that skeletal muscle convective
nd diffusive O2 transport play in limiting exercise capacity
n patients with CHF and provide direction for future
harmacologic and rehabilitative interventions in this
opulation.
ethods
ubjects. Six male clinically stable patients with CHF
New York Heart Association [NYHA] functional class II
o III, Weber VO2max Class C/B [12]), and 6 healthy male
ontrols volunteered and gave written informed consent to
articipate in this study, which had been approved by the
niversity of California, San Diego Human Subjects Pro-
ection Program. Mean left ventricular ejection fraction in
Abbreviations
and Acronyms
CaO2  arterial O2
concentration
CHF  chronic heart failure
DMO2  diffusive muscle
O2 conductance
KE  knee-extensor
exercise
Ne  norepinephrine
NYHA  New York Heart
Association
QO2  oxygen delivery
SNA  sympathetic
nervous system activity
VO2  oxygen uptakehe CHF patients was 25  3%. Other than beta-blockers, Ahich were withheld for 48 h prior to the studies, patient
edications were not altered throughout the study. Partic-
lar care was taken to match patients with CHF and
ontrols in terms of age, sex, and especially, physical activity
y questionnaire and interview (Table 1).
atheter placement, and experimental and training protocol.
pon arrival at the laboratory, following a series of famil-
arization sessions, the study participants had radial arterial
nd common femoral venous catheters placed. In addition,
thermocouple sensor was placed in the common femoral
ein, as previously described (13). Following these proce-
ures, all subjects undertook 4 exercise tests in a balanced
esign, each separated by at least 1.5 h for recovery (cycle
nd KE in both normoxia and hyperoxia [100% O2]). In
ach trial, exercise intensity was incremented progressively
very 2 min to exhaustion. On a separate day, a percutane-
us biopsy of vastus lateralis muscle was obtained (Berg-
trom needle) from the CHF patients and controls, as
reviously described (14). These catheter-based and biopsy
tudies were then repeated in the CHF patients following 8
eeks of supervised KE training (3 times/week, varied
ntensity, with overall intensity progressively increased based
pon biweekly assessments, 50 min/session/leg), as previ-
usly described (15–17). Exercise training compliance was
valuated as a percentage of training sessions attended.
ontrol subjects did not undergo training and thus were
tudied only once.
xercise modalities. Cycle exercise was performed on an
lectromagnetically braked cycle ergometer (Lode Excalibur
port, Quinton Instruments Inc., Groningen, the Nether-
ands). During KE, the subject was seated on an adjustable
hair with the ankle of 1 leg attached by a rigid bar to a cycle
rgometer (Monark), as previously described (18) (Fig. 1).
Characteristics of Patients With CHFand of ControlTable 1 Characteristics of Patients With CHFand of Controls
CHF Pre CHF Post Controls
Age, yrs 54 14 54 14 51 8
Height, cm 182 6 182 6 179 7
Body mass, kg 100 4† 101 4† 90 11
Knee extensor, 1 leg muscle mass, kg 2.6 0.3 3.0 0.4*† 2.4 0.4
NYHA functional class II–III II–III —
Medications % Using % Using % Using
Digoxin 100% 100% 0%
Diuretics 100% 100% 0%
Long-acting nitrates 80% 80% 0%
Statins 60% 60% 0%
Aspirin 80% 80% 0%
Beta-blockers 100% 100% 0%
Warfarin 40% 40% 0%
ACE inhibitors 80% 80% 0%
Ca-channel blockers 40% 40% 0%
Values are mean  SD, unless otherwise noted. *p  0.05 (post vs. pre); †p  0.05 (CHF vs.
ontrols).
ACE  angiotensin-converting enzyme; CHF  chronic heart failure; NYHA  New York Heart
ssociation.
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September 20, 2011:1353–62 Peripheral Adaptation in Heart FailureMeasurements and calculations. Mixed expired O2 and
CO2, expiratory air flow and electrocardiograms were con-
tinuously recorded and digitized (Parvo Medics, Salt Lake
City, Utah). Radial arterial and common femoral venous
blood samples were collected at rest and during the third
minute of each incremental work rate. At each level of work,
the following variables were measured from these samples:
PO2, PCO2, pH (IL model 1302, pH/blood gas analyzer,
Instrumentation Laboratories, Milan, Italy), oxyhemoglo-
bin saturation, hemoglobin concentration ([Hb]) (IL 482
co-oximeter), and lysed whole-blood lactate concentrations
[La] (YSI 23L blood lactate analyzer; Yellow Springs
Instruments, Yellow Springs, Ohio). Blood gas values were
corrected to the temperature measured in the common
femoral vein. In addition, common femoral venous blood
flow (thermodilution) and arterial and venous pressures
were measured (18). Muscle O2 diffusional conductance
(DMO2) and mean capillary PO2 (PcapO2) were calculated as
escribed previously (19,20). Briefly, a numerical integra-
ion procedure is used to determine that value of DMO2,
assumed constant along the capillary, that produces the
measured femoral venous PO2, given the measured arte-
ial PO2. Additional explicit assumptions of this calcula-
tion are: 1) mitochondrial PO2 is negligibly small at
VO2max; and 2) the only explanation of O2 remaining in
the femoral venous blood is diffusion limitation of O2
efflux from the muscle microcirculation. PcapO2 is the
numerical average of all PO2 values computed, equally
spaced in time, along the capillary from the arterial to the
venous end. Further technical aspects of these measure-
ments and subsequent calculations have been previously
Figure 1
The Time Course for Maximal
KE Work Rate Improvement and
Pre- and Post-Training Muscle VO2peak
The time course of improvement and peak oxygen uptake (VO2peak) is shown
over 8 weeks of knee-extensor exercise (KE) training in patients with chronic
heart failure (CHF). Line plot represents maximum work load assessed every
2 weeks (left y-axis) and bars represent leg VO2 assessed before and after
exercise training (right y-axis). *p  0.05 versus pre-training condition.provided in detail (19,20).Cardiac output. Cardiac output was measured in duplicate
at rest and during exercise using an open-circuit acetylene
(C2H2) uptake technique, as described previously (21).
Catecholamines. Epinephrine and norepinephrine (Ne)
were extracted from plasma using a cis-diol-specific affinity
gel, acylated, derivatized enzymatically, and then assayed by
competitive ELISA using the microtiter plate format, as
previously described (22). The rate of Ne spillover was
determined as described previously (23) using the following
equation:
Ne spillover CvCaCa Ee·LPF
where Cv and Ca are plasma Ne concentrations in the
common femoral vein and radial artery, respectively. Ee is the
fractional extraction of epinephrine, and LPF is the leg plasma
flow, determined from leg blood flow and hematocrit.
Muscle mass. With thigh length, circumferences, and
skinfold measurements, thigh volume was calculated to
allow an estimate of quadriceps muscle mass, as utilized
previously (18,24). During cycle exercise, the amount of
working muscle mass was estimated based on the reported
ratio of quadriceps muscle mass to other leg muscles, in a
similar fashion to what we had previously done (25).
Muscle biopsy handling. The percutaneous biopsy sam-
ples from the Vastus lateralis ( 80 to 100 mg) were equally
divided for histochemistry and microscopy, with the former
being oriented for future sectioning and then frozen,
whereas the latter were fixed with glutaraldehyde.
Histochemistry. Eight-micron-thick transverse sections
were cut at 24°C on a cryostat (Jung-Reichert Cryocut
1800) and kept at 20°C until histochemical processing,
which was performed within a week of sectioning. After
5-min fixation in a Guth and Samaha fixative at room
temperature, sections were incubated at 37°C for 1 h in lead
(Pb)-ATPase staining medium to simultaneously stain for
fiber types I and II and capillaries (26).
Tissue preparation for microscopy. The glutaraldehyde-
fixed samples were completely cut into thin longitudinal
strips and processed for electron microscopy as described
previously (27). Electron micrographs for morphometry
were taken on 70-mm films with a Zeiss 10 electron
microscope (Carl Zeiss, Oberkochen, Germany).
Morphometry. The relative cross-sectional area and num-
ber of type I and type II fibers were estimated under a light
microscope (250) on histochemical sections by point-
counting using an eyepiece square grid test A100 (28).
Capillary density (i.e., capillary number per fiber cross-
sectional area), capillary-to-fiber ratio (i.e., capillary number
per fiber number), capillary number around a fiber, and fiber
cross-sectional area were measured by point-counting on
1-m-thick sections examined at a magnification of 400
with a light microscope. The volume density of mitochon-
dria per volume of muscle fiber was estimated by point-
counting using electron microscopy at a final magnification
of 49,000 on ultrathin transverse sections.
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Peripheral Adaptation in Heart Failure September 20, 2011:1353–62Statistical analysis. Data were analyzed using parametric
statistics, following mathematical confirmation of normal dis-
tribution using Shapiro-Wilk tests. Within-group subject as-
sessments (CHF) were achieved using paired sample t tests or
ANOVA for repeated measurements, whereas CHF patient
and control data were compared using unpaired t tests or
NOVA, where appropriate. Following a significant main
ffect and interaction with an ANOVA, t tests were employed
o make post hoc comparisons. Due to the limited sample size
nd large number of measurements, post hoc comparisons
ere not corrected for multiple comparisons, and this is a
ecognized limitation of the statistical analyses employed. The
elationship between selected variables was identified using a
earson product moment correlation. Statistical significance
as set at p 0.05. Unless otherwise stated, data are expressed
s mean  SE.
esults
he Shapiro-Wilk tests revealed p values 0.05; thus, the
ull hypothesis that the data were normally distributed was
ot rejected, and parametric statistics were employed.
ubject characteristics. Prior to exercise training, the only
tatistically significant different anthropometric charac-
eristic between the patients and controls was body mass,
hich was higher in patients. Post-training, body mass
as unchanged, whereas quadriceps muscle mass was
5% greater (Table 1). As a consequence of the KE
raining–induced increase in cycle VO2max (Table 2), the
patients who, pre-training, were predominantly catego-
rized as Weber VO2max Class C (12) were now predom-
nantly Class A and B.
Cardiorespiratory and Metabolic Responses to Maximal Normoxic CTable 2 Cardiorespiratory and Metabolic Responses to Maxima
Cycle
CHF Pre CHF Post
Work load, W 115 13* 141 16†
Pulm VO2, l·min
1 1.63 0.09* 2.02 0.15†
Pulm VO2, ml·kg
1·min1 15.3 1.2* 18.6 1.6*†
RER 1.21 0.02* 1.08 0.06
Cardiac output, l·min1 13.6 1.2* 14.3 1.4*
HR, beats·min1 155 5 149 9
Leg blood flow, l·min1 4.62 0.46 5.49 0.52†
Leg O2 delivery, l·min
1 0.86 0.10* 1.05 0.09†
Leg VO2, l·min
1 0.62 0.04* 0.87 0.07†
DMO2, ml·min
1·mm Hg1 14.0 0.9* 21.3 3.4†
Fem arterial pressure, mm Hg 123 15 118 8
Fem venous pressure, mm Hg 11 1* 16 2†
Leg vasc res, mm Hg·ml1·s 1.50 0.22 1.14 0.11†
CaO2, ml·100 ml
1 18.8 1.0* 19.2 0.5*
CaO2–CVO2, ml·100 ml
1 13.7 0.8* 15.8 0.2†
[La]a, mmol·l
1 6.3 0.9 6.8 1.4
PcapO2, mm Hg 42.4 1.1 41.2 2.8
Values are mean  SE. *p  0.05 (CHF vs. controls). †p  0.05 (post vs. pre).
CaO2  arterial O2 content; CaO2-CVO2  arterial-venous O2 content difference; CHF  chron
nee-extensor exercise; [La]a arterial lactate concentration; Leg vasc res 1-leg vascular resistance; leg
muscle; PulmVO2  pulmonaryVO2; RER  respiratory exchange ratio.xercise training compliance. The individualized ap-
roach to training with supervision in the laboratory re-
ulted in a 98% compliance to the prescribed exercise
egimen. A single patient did not complete the post-
raining tests due to sickness and so was excluded from all
nalyses.
aximal KE exercise pre- and post-KE training. Maxi-
um work rate during single-leg KE increased substantially
n the first 2 weeks of training and continued to rise over the
ext 4 weeks, with little measurable increase in the final 2
eeks of training (Fig. 1), on average, almost doubling from
9 to 37 W to equal that of the (untrained) control subjects.
re-training, cardiac output attained during maximal KE in
he patients with CHF was not significantly different than
n controls and was not altered by KE training (Table 2).
re-training, maximum leg O2 delivery was significantly
lower than in controls, but post-training patient maximum
leg O2 delivery increased to equal that of the controls, in
both cases driven by differences in blood flow and not O2
content (Table 2). Leg vascular resistance at maximal
exercise was significantly attenuated after exercise training;
however, the assessment of Ne spillover across the muscle
bed did not implicate a reduction in muscle sympathetic
nerve activity (Table 3). Pre-training, DMO2 at maximal
E was significantly lower in CHF patients than controls.
ost-training, DMO2, although tending to be higher, was
ot significantly different from controls (p  0.1) (Table 2,
igs. 2 and 3). Pre-training, KE leg VO2peak was signifi-
antly lower in patients compared with controls. However,
ost-training, patient leg VO2peak increased and was signif-
icantly greater than in controls (Table 2, Figs. 1 and 2).
and KE in Patients With CHF and in Controlsmoxic Cycle and KE in Patients With CHF and in Controls
KE
Controls CHF Pre CHF Post Controls
48 8 19 2* 37 5† 35 4
.14 0.10 0.76 0.08* 1.08 0.05† 1.12 0.09
4.1 1.1 7.0 0.4* 9.9 0.7† 12.71.2
.05 0.02 1.11 0.12* 1.06 0.06* 0.86 0.03
6.8 0.8 9.0 1.2 9.4 1.1 10.9 1.2
56 9 101 6* 107 7 116 6
.19 0.37 3.09 0.24 4.27 0.46*† 3.6 0.24
.06 0.07 0.53 0.03* 0.79 0.09† 0.7 0.04
.77 0.06 0.39 0.02* 0.60 0.07*† 0.49 0.03
8.7 1.3 10.1 0.8* 14.0 2.3† 12.1 0.9
32 14 113 3* 123 7* 149 9
19 3 16 2 18 2 16 4
.38 0.20 1.89 0.20* 1.58 0.23*† 2.31 0.24
0.4 0.2 17.4 1.0* 18.6 0.9 19.6 0.3
5.3 0.8 13.0 0.8 14.3 1.1† 13.8 0.5
6.4 0.8 2.7 0.3 3.4 0.5 3.2 0.3
1.3 2.0 38.5 0.8* 43.6 2.4† 41.3 0.8
t failure; DMO2  muscle O2 diffusional conductance; fem  femoral; HR  heart rate; KE yclel Nor
1
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VO2 1-leg O2 uptake; PcapO2 calculated partial pressure of O2 in the capillaries of the exercising
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September 20, 2011:1353–62 Peripheral Adaptation in Heart FailureMaximal cycle exercise pre- and post-KE extensor
training. Pre-training, cardiac output attained during maxi-
mal cycle exercise in the patients was significantly lower than in
the controls and was unaffected by training (Table 2). Pre-
Arterial and Venous Epinephrine, Ne, and Calculated Ne SpilloverF om the Muscle During Maximal Cycle and KE in Controls and PaTable 3 Art rial a d Venous Epinephrine, Ne, and Calcu ated NFrom the Muscle During Maximal Cycle and KE in Con
Cycle
CHF Pre CHF Post
[e]a, nmol·l
1 2.2 0.5 3.6 1.5
[e]v, nmol·l
1 1.8 0.5 3.4 1.5
[Ne]a, nmol·l
1 27.2 6.1* 30.1 5.5*
[Ne]v, nmol·l
1 24.0 4.3* 32.1 4.4*
Ne spillover, nmol·l1·min1 10.7 3.1 10.2 3.7
Values are mean  SE. *p  0.05 (CHF vs. controls).
[e]a  arterial epinephrine concentration; [e]v  femoral venous epinephrine concentration; [N
spillover,  norepinephrine spillover in 1 leg; other abbreviations as in Table 2.
Figure 2 A Comparison of Oxygen Transport
and Utilization Parameters
Parameters were assessed at maximal cycle (upper panel) and knee-extensor
exercise (KE) (lower panel) both before and after KE training in patients with
chronic heart failure (CHF) (n  5) normalized to values from healthy controls
(n  6). CaO2-CVO2  arterial-venous O2 content difference; leg QO2  1-leg O2
delivery; leg VO  1-leg O uptake.2 2training, maximum leg cycle O2 delivery in the patients was
also significantly lower than in controls, but post-training,
maximum leg O2 delivery increased to equal that of the
controls, in both cases driven by differences in blood flow and
not O2 content (Table 2). Leg vascular resistance at maximal
exercise was significantly attenuated after exercise training;
however, as with KE exercise, Ne spillover across the muscle
bed did not suggest a reduction in muscle sympathetic nerve
activity (Table 3). Pre-training, DMO2 at maximal cycle
exercise in the patients with CHF was significantly lower than
in controls. Post-training, DMO2, although tending to be
igher, was not statistically different from controls (p  0.1)
Table 2, Figs. 2 and 3). Both pulmonary and leg VO2peak were
significantly lower in the patients compared with controls
during maximal cycle exercise pre-training; however, after
training, both cycling pulmonary VO2peak and leg VO2peak
increased to equal that of controls (Table 2, Figs. 1 and 2).
Catecholamines. Resting arterial norepinephrine, an index
of CHF severity, was significantly higher in the patients
both before (4.7  2.9 nmol/l) and after (4.2  2.6 nmol/l)
With CHFllover
and Patients With CHF
KE
Controls CHF Pre CHF Post Controls
1.0 0.1 0.9 0.3 1.3 0.5 0.6 0.1
0.8 0.1 0.8 0.3 1.1 0.4 0.5 0.1
18.3 3.5 6.0 0.9 8.0 0.8 8.6 2.2
17.6 5.2 6.9 1.1 8.5 1.2 9.3 2.1
7.9 2.3 4.3 2.4 5.0 2.7 4.9 1.7
rterial norepinephrine concentration; [Ne]v  femoral venous norepinephrine concentration; Ne
Figure 3 The Improvement in Skeletal Muscle DMO2
in Relation to Leg VO2peak
Improvement is shown during maximal bike and KE afforded by 8 weeks of KE
training in patients with CHF, compared with healthy controls. Note the correla-
tion coefficient only represents the relationship between the individual data.
Abbreviations as in Figures 1 and 2.tientse Spi
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Peripheral Adaptation in Heart Failure September 20, 2011:1353–62training compared with controls (3.2 0.5 nmol/l) and was
ot significantly reduced by the exercise training. During
ycling, the assessment of arterial and venous cat-
cholamines at maximal exercise revealed a tendency for
reater arterial and venous epinephrine and Ne and calcu-
ated Ne spillover across the quadriceps in the patients with
HF. However, likely due to large individual variations,
his effect only achieved significance for arterial and venous
e on the cycle ergometer, both before and after training.
uring KE, the catecholamine data were more similar
etween patients and controls, and there was no apparent
mpact of training (Table 3).
uscle structure. Prior to training, the muscle character-
stics for both patients with CHF and controls were very
imilar, with no significant difference in fiber cross-sectional
rea, percent area of type I and II fibers, capillary density,
apillary-to-fiber ratio, or number of capillaries around a
ber between patients and controls. However, mitochon-
rial volume density was significantly lower in the patients
ith CHF. As a consequence of training, the patients
xhibited a significant increase in fiber cross-sectional area,
apillary-to-fiber ratio, number of capillaries around a fiber,
nd mitochondrial volume density. This increase in mito-
hondrial volume density was such that, post-training, there
as no longer a difference between patients and controls, as
as the case with all other structural variables measured
Table 4).
00% O2 breathing. At both peak cycle exercise and KE
prior to and following training, hyperoxic breathing in the
patients with CHF increased CaO2 by 8% to 10 % (p 
.05), with no significant effect on leg blood flow. There-
ore, leg O2 delivery also increased by 5% to 9% (p  0.05),
but leg VO2peak was unaffected by this increased O2 avail-
ability in each scenario.
Correlative analyses. With the inclusion of all normoxic
scenarios studied (i.e., CHF patients and controls on the
cycle and KE, and patients again on these 2 modalities after
training), there was a wide range of values of DMO2 and leg
O2peak data. A Pearson’s correlation analysis revealed that
here was a strong and significant relationship (r  0.85)
etween DMO2 and leg VO2peak across all these paradigms
Vastus Lateralis Muscle CharacteristicsTable 4 Vastus Lateralis Muscle Characteristics
CHF Pre CHF Post Controls
Fiber cross-sectional area, m2 3,458 204 4,074 215* 3,853 606
% area of type I fibers 34 4 41 3* 41 4
% area of type II fibers 66 4 59 3* 59 4
Capillary density,
capillaries·mm2
498 23 484 23 415 46
Capillary-to-fiber ratio 1.6 0.1 1.8 0.1* 1.5 0.10
Number of capillaries
around a fiber
3.6 0.2 4.3 0* 3.8 0.1
Mitochondrial volume density, % 3.8 0.3† 4.9 0.4* 4.4 0.4
Values are mean  SE. *p  0.05 (post vs. pre); †p  0.05 (CHF vs. controls).
CHFR  chronic heart failure.Fig. 3). An additional correlation, of note, was the rela-ionship between mitochondrial volume and number of
apillaries around a fiber. Specifically, the combination of
oth pre- and post-KE training data for the CHF patients
evealed a significant correlation between these 2 physiolog-
cally important variables (Fig. 4).
iscussion
ere, with the intent to elucidate the mechanisms respon-
ible for improvements in whole-body exercise capacity
hen exercise training of a small muscle mass is employed in
atients with CHF, we studied the determinants of VO2peak
during both KE and cycle exercise before and after 8 weeks
of KE training. As anticipated, this intervention had no
effect upon maximal cardiac output, because this exercise
training paradigm only minimally stresses the heart and was
therefore unlikely to stimulate central hemodynamic adap-
tations. In contrast, there were a multitude of significant
peripheral structural and functional adaptations that con-
tributed to improved patient exercise capacity, both during
maximal small muscle mass and whole-body exercise. Spe-
cifically, in addition to significant training-induced muscle
morphometric changes, both convective and diffusive O2
transport were increased at maximal KE and cycle exercise,
yielding a significant increase in VO2peak in each scenario.
These peripheral structural and O2 transport improvements,
ithout a change in cardiac output, provides evidence of
ignificant peripheral vascular and metabolic plasticity in
his population that can be developed in isolation with small
uscle mass training and then harnessed to the benefit of
hole-body exercise capacity. Additionally, these findings
ighlight the importance of skeletal muscle–specific adap-
ations in patients with CHF allowing the contributions of
Figure 4 Correlation Between the Number of Capillaries
Around a Fiber and Mitochondrial Volume
The correlation is shown in patients with chronic heart failure (CHF) before and
after 8 weeks of knee-extensor training. Note the correlation coefficient only
represents the relationship between the individual data.
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clinical interventions in the future.
Small muscle mass exercise training–induced changes in
O2 transport. Previously (7), building upon the initial
ork of Poole and Musch in a rat model of CHF (5,6), we
ave documented the contributions of both the convective
bulk delivery of O2) and diffusive (movement of O2 from
emoglobin to mitochondria) elements in determining
O2peak in CHF patients and contrasted these findings with
ge- and activity-matched healthy controls. In the current
tudy, we have the opportunity to elucidate the effect of
mall muscle mass training, which did not alter maximal
ardiac output, in patients with CHF, on the convective and
iffusive components of O2 transport that ultimately deter-
mine VO2peak, again with age- and activity-matched controls
s a reference (Tables 1 and 2). Here, the main findings are
hat deficits in O2 delivery and DMO2 that result in an
attenuated VO2peak are evident equally at maximal exercise,
whether performed on a cycle or KE ergometer, and can be
restored to, or even exceed (i.e., KE VO2peak), levels of
ormal but untrained controls by 8 weeks of KE training
Figs. 2, 3, and 5).
One method to better understand these interactions is by
Figure 5 A Schematic Illustration of the Convective and
Diffusive Components That Interact to Determine VO2peak
Shown are the components in both chronic heart failure and control subjects
during cycle (large muscle mass) and knee-extensor exercise (KE, small muscle
mass) and the subsequent changes as a consequence of KE training. Dotted
lines represent Fick law and principle lines for the controls (intersecting at A;
control VO2peak), whereas the solid lines represent the patients with CHF. Fol-
lowing training, both groups share the dotted Fick principle line. In both exer-
cise modalities, prior to training, the patients with CHF exhibited attenuated
convective and diffusive oxygen transport as evidenced by their VO2peak being
defined by the intercept of lower Fick law and principle lines (C). B indicates
the less severe reduction in VO2peak had the patients only revealed a reduction
in convective O2 transport. KE training corrected both of these deficits, without
increasing cardiac output, restoring both skeletal muscle convective and diffu-
sive O2 transport and therefore allowing VO2peak to equal or exceed (KE) that of
the healthy controls (E). D represents the consequence of exercise training if
the increase in VO2peak had only been driven by an increase in convective O2
transport (C to D). Abbreviations as in Figure 1.he representation of both the diffusive component of O2 mtransport, which is defined by Fick’s law of diffusion (VO2
MO2  K  PVO2, where K is a constant that takes into
account the proportionality between mean capillary PO2 and
VO2 and the assumption that intracellular PO2 is very close
o zero) (13), and the convective component, that is defined
y the Fick principle (VO2 blood flow  [CaO2 
VO2]), in a model that links VO2peak and effluent muscle
O2 (PVO2) to explain limitations to maximal exercise
capacity (Fig. 4) (29). At this point, it is important to
recognize that based upon our previous work (7) and the
current findings, the same schematic can be used to illustrate
the results of both KE and cycle exercise studies. This is
because, despite the fact that maximal cycle exercise un-
doubtedly completely taxed cardiac output capacity and KE
had a cardiac reserve (7), prior to exercise training both the
convective and diffusive components of O2 transport of the
patients were attenuated, regardless of exercise modality
(Figs. 2 and 5) and then were restored in both modalities in
a remarkably similar fashion as a consequence of KE
training.
With this model of the determinants of VO2peak, it can be
seen (Fig. 5) that before KE training, if the only difference
between the controls and the CHF patients were the
reduced convective component of O2 transport (Table 2),
then VO2peak would have fallen from A to B as a result of
this pathology (6). However, in addition to the lower
convective component of O2 transport, the patients with
HF also revealed a significantly attenuated DMO2 (diffu-
ive component) (Figs. 2, 3, and 5), which actually resulted
n an even greater fall in peak VO2peak from A to C (Fig. 5).
ikewise, this graphical illustration of the current data
eveals that the consequence of exercise training was the
esult, not only of a blood flow–driven increase in convec-
ive O2 transport (C to D) or the restoration of DMO2 to
hat of controls (C to B) or higher, but a combination of
hese phenomenon (C to E) that resulted in the large
ncrease in VO2peak (Figs. 1, 2, 3, and 5). These findings
ave several important implications. First, that patients with
HF exhibit significant plasticity in terms of their ability to
espond to exercise training both in terms of skeletal muscle
lood flow changes and diffusional O2 transport. Second,
both of these KE training–induced adaptations (augmented
peripheral convective and diffusive O2 transport) translate
into improvements in whole-body exercise capacity (cycle)
without a requisite improvement in cardiac function.
Catecholamines and O2 delivery. Neurohumoral activa-
ion, including increased sympathetic nervous system activ-
ty (SNA), is a hallmark of advanced CHF, and those
atients with the greatest SNA have the poorest chance of
urvival (30). So strong is this link, virtually every pharma-
ological therapy proven to increase survival in CHF inter-
upts this increase in SNA (31). Exercise training, on the
ther hand, has clear beneficial effects, but data regarding
he effect of exercise training on SNA in CHF have been
quivocal. For example, direct SNA measurements with
icroneurography revealed a clear reduction in resting SNA
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whereas a study, more similar to the current work, evaluated
patients with CHF before and after 8 weeks of 2-legged KE
training. This study yielded many apparent benefits, but
training did not alter resting Ne levels (33). The current
study supports the latter findings, with resting arterial Ne
levels being significantly higher than the healthy controls
before KE training, and this difference was maintained
following the exercise intervention, although it should be
noted that there was a tendency for levels to decrease.
Additionally, during exercise, there was evidence of rela-
tively elevated Ne levels in the patients with CHF and a
tendency for greater vascular resistance, attenuated blood
flows, and consequently significantly attenuated O2 delivery
rior to exercise training, which was reversed by KE training
espite unremarkable changes in Ne levels (Tables 2 and 4).
hus, although somewhat indirect, the current data fail to
upport an obligatory association between the benefits of
xercise training and a reduction in SNA in patients with
HF. It is, of course, plausible that other exercise training–
nduced vascular adaptations, such as improved vascular
ndothelial function, were responsible for the reduction in
ascular resistance in the patients with CHF, but this is
eyond the scope of the current study. Also in terms of all
he catecholamine data, it is interesting to note the much
ore similar findings in the patients and controls during KE
xercise compared with cycle exercise, which is likely a
onsequence of the far less globally taxing nature of KE
xercise.
keletal muscle structural plasticity. A significant
trength of the current study was the potential, not only to
erform the functional assessment VO2peak and dissect
hanges in the determining factors of this important vari-
ble, but also to directly examine concomitant changes in
uscle structure (Table 4). Other studies of skeletal muscle
tructure and function within and between species have
evealed design features that are uniform throughout mus-
les of widely varying metabolic demand. Such studies have
evealed that the size of the capillary-to-fiber interface is
atched to mitochondrial volume/fiber length in response
o stimuli such as chronic hypoxia (34), electrical stimula-
ion (35), and physical activity (36). These observations
uggest that another regulated design feature in skeletal
uscle is the matching of structural capacity for O2 flux to
fiber metabolic demand, as previously reported (36). The
current data (Fig. 4), in which mitochondrial volume and
capillarity and the changes in these variables due to KE
training appear to be well related, again reveals a positive
and physiologically expected relationship in patients with
CHF. Thus, not only does this study document a degree of
normalcy in these patients in terms of the components of O2
supply and demand, but it also emphasizes the fact that they
retain the plasticity to respond to an exercise training
stimulus (Fig. 4).
Skeletal muscle metabolic reserve and exercise training. Pre-
iously, we have documented that by switching from a large(cycle) to a small (KE) muscle mass exercise modality, a
cardiac reserve was available to both patients with CHF and
controls (7), and this was again the case in these subjects
(Table 2). This central reserve, with the appropriate nor-
malization to muscle mass involved in the exercise (25),
ranslated into a clear improvement in muscle blood flow
nd metabolic capacity in patients with CHF and controls
hat was accessible during KE (Table 2). This observation is
f specific interest in light of the many previous studies that
ave suggested CHF-induced skeletal muscle exhibits a
hift in fiber type distribution, reduced oxidative capacity,
educed mitochondrial-based enzymes, and decreased mi-
ochondrial volume density, all as a consequence of either
uscle atrophy or myopathy, or both (1,37–39). Therefore,
n this population, it is a significant observation that there
till appears to be a metabolic reserve at maximal exercise,
pparent when skeletal muscle is freed from the restraints
mposed by the failing heart and that KE training can
ugment this reserve.
By increasing O2 availability, breathing 100% O2, we
have previously also documented that patients with CHF
can exhibit a skeletal muscle metabolic reserve (7). That is,
when breathing hyperoxia, which resulted in an elevated
arterial O2 content, these patients were able to achieve a 5%
greater cycle work rate and a 7% increase in VO2peak, and
interestingly, this hyperoxic benefit was not achieved during
KE. The current patients contrast with this previous report,
responding more in line with the healthy controls, who
failed to increase VO2peak above that attained in normoxia
when breathing hyperoxia in both modalities (7). This
failure to improve exercise capacity when provided with
greater O2 availability (40,41), suggests that in these pa-
ients ambient O2 was either perfectly matched or in excess
f basal muscle metabolic capacity. This sets the stage for a
eassessment following an exercise-induced increase in met-
bolic capacity. Somewhat disappointingly, 8 weeks of KE
raining and subsequent testing in hyperoxia did not signif-
cantly elevate VO2peak above the level achieved in normoxia
ither during KE or cycle exercise, despite clear increases in
itochondrial volume (Tables 2 and 4). A potential expla-
ation for this conundrum may be related to the actual
elivery of this increased O2 in the microcirculation and the
ubsequent matching of O2 supply and metabolic demand in
this population, but this hypothesis is not addressed in the
current study and will therefore require further investigation.
Experimental consideration. Although beta-blockers were
withheld from the patients for 48 h prior to testing, to allow
an unrestrained heart response to maximal exercise, other
patient medications were not altered throughout the study.
As documented in Table 1, the medication regimen of these
patients was considerable, many with direct vascular conse-
quences. Therefore, although unavoidable for ethical rea-
sons, the potential impact of these medications and possible
interaction with the KE training cannot be disregarded.
This is a significant limitation of both the current study and
the majority of work performed in this population. It should
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with CHF, this work focused upon patients with a NYHA
functional classification of II and III and not the most
impacted patients (class IV). This was not due to concern
regarding exercise testing, but rather a consequence of
subject availability due to the more common use of left
ventricular assist devices and early heart transplantation in
the most severely affected patients. This may have skewed
the data in terms of the potential impact of CHF on exercise
capacity and exercise training–induced plasticity; however,
due to the aforementioned interventions, NYHA functional
class II and III CHF patients are now the predominant
category in this population.
Conclusions
Despite continued central hemodynamic limitations, clear
improvements in muscle structure, peripheral convective,
and diffusive O2 transport, and subsequently, O2 utilization,
ll reveal the mechanisms of, and provide support for, the
fficacy of local skeletal muscle training as a powerful
pproach to decrease exercise intolerance in patients with
HF. These mechanistic findings may have important
ractical consequences in terms of guiding future pharma-
ological and rehabilitative interventions in this population.
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